Skip to content

Batch information on every product pageTHC < 0.3%Shipped from France10% off when you sign up

CBN-C4Cannabinol butyl

Butyl (C4) homologue of cannabinol, tentatively reported in cannabis in 1976, with no measured pharmacology.

Level of detail

Harm-reduction warning

No characterised human dose: animal / in vitro data only. Effect profile, safety margin and acute toxicity are not documented in human clinical practice. Extremely potent compound: severe effects, seizures and deaths reported in the literature.

C₂₀H₂₄O₂

CAS 60007-99-0

Family
PhytocannabinoidMinor
Origin
Tentative identification
Molar mass
296.40 g/mol

Updated on

In plain terms

Butyl cannabinol is a close relative of CBN whose side chain has four carbons instead of five. It was reported in two cannabis samples in 1976, by an identification that remains tentative. What it does in the body has not been measured.

Receptors and activity

    Bar length follows the measured value (Ki, Kd, EC50 or IC50), on one scale shared by every entry, from 100 µM to 0.1 nM. A target with no cited value has no bar.

    Pharmacology

    Butyl cannabinol (CBN-C4) is the butyl-chain homologue of cannabinol: the same aromatised benzo[c]chromene skeleton, with no stereocentre, but four side-chain carbons instead of five. Harvey reported it in 1976 in two cannabis samples, by gas chromatography coupled with mass spectrometry, together with the butyl homologues of Δ9-THC, its acid and CBD; this identification remains tentative, without isolation. If present, it would form like cannabinol by oxidation of its tetrahydro precursor, tetrahydrocannabutol, which has not been studied. No affinity constant, no screen at other targets and no pharmacokinetic, metabolism or toxicology data were found. In France, its structure falls within the generic class of benzo[c]chromene derivatives created by the ANSM in 2024, from which only CBN and CBNA are excluded by name among the cannabinols.

    History

    Source
    Cannabis sativa L.: tentative identification only, by GC-MS in two cannabis samples (Harvey 1976), without isolation. If it is indeed present, it would form like cannabinol, an oxidation product of Δ9-THC, from tetrahydrocannabutol; this lineage has not been studied. Origin not established.

    Biosynthetic pathway

    No formation pathway has been demonstrated for CBN-C4. By analogy with cannabinol, which results from the oxidation of Δ9-THC and not from a plant enzyme, formation by aromatising oxidation of tetrahydrocannabutol is plausible, but no study has established it.

    Classification

    Family, origin and source verification

    Family

    Phytocannabinoid › Minor

    Presence in the plant

    Tentative identification, never isolated

    Chemistry

    Type CBN · C4 side chain · neutral form

    Verification

    Every fact on this entry was checked against its primary sources on 20 October 2026.

    Wikipedia (English)

    No dedicated article.

    References

    Identifiers

    Names

    Common name
    Cannabinol butyl
    IUPAC name
    3-butyl-6,6,9-trimethylbenzo[c]chromen-1-ol
    Other names
    CBN-C4 · cannabinol-C4 · 3-butylcannabinol

    Identifiers

    Formula
    C₂₀H₂₄O₂
    CAS
    60007-99-0
    InChIKey
    GGVVJZIANMUEJO-UHFFFAOYSA-N
    SMILES
    CCCCC1=CC(=C2C(=C1)OC(C3=C2C=C(C=C3)C)(C)C)O

    Machine-readable entry (JSON)

    LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.